| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 2.260.539 $ | 99,85 | 122.325 | |||||||
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 102.819 $ | 4,54 | 2.024 | |
| Johnson & Johnson | Johnson & Johnson COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 71.376 $ | 3,15 | 292 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 63.449 $ | 2,80 | 107 | |
| Pfizer Inc. | Pfizer Inc. COM | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 62.001 $ | 2,74 | 2.208 | |
| Eli Lilly & Co. | Eli Lilly & Co. COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 59.785 $ | 2,64 | 65 | |
| Stoke Therapeutics Inc | Stoke Therapeutics Inc COM | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 57.273 $ | 2,53 | 1.759 | |
| NATERA INC | Natera Inc. COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 57.197 $ | 2,53 | 286 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 53.129 $ | 2,35 | 151 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation COM | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 52.415 $ | 2,32 | 1.103 | |
| AstraZeneca PLC | AstraZeneca PLC ORD USD0.25 | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 51.672 $ | 2,28 | 262 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc SPONSORED ADS | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 49.839 $ | 2,20 | 1.034 | |
| Amicus Therapeutics Inc. | Amicus Therapeutics Inc. COM | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 49.670 $ | 2,19 | 3.435 | |
| BioNTech SE | BioNTech SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 47.373 $ | 2,09 | 533 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 46.631 $ | 2,06 | 621 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 44.320 $ | 1,96 | 318 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG NAMEN AKT | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 42.385 $ | 1,87 | 891 | |
| Immunome Inc | Immunome Inc COM | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 42.165 $ | 1,86 | 1.928 | |
| Novonesis (Novozymes) B | Novonesis (Novozymes) B SER'B'DKK2 | EC | DK0060336014 | Long | Börsenkurs (Stufe 1) | 41.934 $ | 1,85 | 711 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics Inc. COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 41.131 $ | 1,82 | 1.726 | |
| 10X Genomics Inc | 10X Genomics Inc CL A COM | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 40.337 $ | 1,78 | 1.900 | |
| Darling Ingredients, Inc | Darling Ingredients, Inc COM | EC | 237266101 | Long | Börsenkurs (Stufe 1) | 38.471 $ | 1,70 | 622 | |
| Novartis AG | Novartis AG CHF0.49 (REGD) | EC | CH0012005267 | Long | Börsenkurs (Stufe 1) | 37.301 $ | 1,65 | 248 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 36.204 $ | 1,60 | 1.307 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 35.648 $ | 1,57 | 138 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals Inc COM | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 35.454 $ | 1,57 | 1.048 | |
| Bunge Global SA | Bunge Global SA COM SHS | EC | CH1300646267 | Long | Börsenkurs (Stufe 1) | 34.853 $ | 1,54 | 274 | |
| Novo Nordisk A/S | Novo Nordisk A/S SER'B'DKK0.1 | EC | DK0062498333 | Long | Börsenkurs (Stufe 1) | 33.645 $ | 1,49 | 945 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 33.614 $ | 1,48 | 2.622 | |
| Corteva Inc | Corteva Inc COM | EC | 22052L104 | Long | Börsenkurs (Stufe 1) | 32.814 $ | 1,45 | 392 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 32.416 $ | 1,43 | 517 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 30.811 $ | 1,36 | 69 | |
| Regenxbio Inc. | Regenxbio Inc. COM | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 29.933 $ | 1,32 | 3.572 | |
| Arcellx Inc | Arcellx Inc COMMON STOCK | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 28.935 $ | 1,28 | 252 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc COM | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 28.241 $ | 1,25 | 11.574 | |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb Company COM | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 27.111 $ | 1,20 | 447 | |
| Takeda Pharmaceutical Co Ltd. | Takeda Pharmaceutical Co Ltd. NPV | EC | JP3463000004 | Long | Börsenkurs (Stufe 1) | 26.417 $ | 1,17 | 742 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 25.497 $ | 1,13 | 33 | |
| Genmab As | Genmab As SPONSORED ADS | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 24.979 $ | 1,10 | 931 | |
| Verbio SE | Verbio SE NPV (BR) | EC | DE000A0JL9W6 | Long | Börsenkurs (Stufe 1) | 23.694 $ | 1,05 | 449 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 23.161 $ | 1,02 | 410 | |
| Bayer AG | Bayer AG NPV (REGD) | EC | DE000BAY0017 | Long | Börsenkurs (Stufe 1) | 22.962 $ | 1,01 | 506 | |
| Argenx SE | Argenx SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 21.177 $ | 0,94 | 29 | |
| Viking Therapeutics Inc. | Viking Therapeutics Inc. COM | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 20.695 $ | 0,91 | 636 | |
| Veracyte Inc | Veracyte Inc COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 20.518 $ | 0,91 | 637 | |
| Editas Medicine Inc | Editas Medicine Inc COM | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 20.210 $ | 0,89 | 8.182 | |
| Danaher Corporation | Danaher Corporation COM | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 20.098 $ | 0,89 | 106 | |
| Arcturus Therapeutics Holdings Inc | Arcturus Therapeutics Holdings Inc COM | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 19.254 $ | 0,85 | 2.494 | |
| ABSCI CORP | Absci Corp. COM | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 18.957 $ | 0,84 | 6.319 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc COM | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 18.508 $ | 0,82 | 5.273 | |
| Tempus AI Inc. | Tempus AI Inc. CL A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 17.636 $ | 0,78 | 390 | |
| Merck & Co., Inc | Merck & Co., Inc COM | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 17.562 $ | 0,78 | 146 | |
| Uniqure N.V. | Uniqure N.V. SHS | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 17.151 $ | 0,76 | 1.049 | |
| Repligen Corporation | Repligen Corporation COM | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 17.084 $ | 0,75 | 145 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 16.683 $ | 0,74 | 91 | |
| Exelixis, Inc. | Exelixis, Inc. COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 16.170 $ | 0,71 | 377 | |
| Zoetis Inc. | Zoetis Inc. CL A | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 15.486 $ | 0,68 | 131 | |
| Revolution Medicines Inc | Revolution Medicines Inc COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 14.879 $ | 0,66 | 153 | |
| Sana Biotechnology Inc | Sana Biotechnology Inc COM | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 14.406 $ | 0,64 | 5.002 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 14.348 $ | 0,63 | 222 | |
| Green Plains Inc. | Green Plains Inc. COM | EC | 393222104 | Long | Börsenkurs (Stufe 1) | 13.966 $ | 0,62 | 849 | |
| Ginkgo Bioworks Holdings Inc | Ginkgo Bioworks Holdings Inc CL A NEW | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 13.431 $ | 0,59 | 2.191 | |
| Zealand Pharma As | Zealand Pharma As DKK1 | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 12.918 $ | 0,57 | 284 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 12.773 $ | 0,56 | 172 | |
| Syensqo SA | Syensqo SA NPV | EC | BE0974464977 | Long | Börsenkurs (Stufe 1) | 12.314 $ | 0,54 | 216 | |
| Geron Corp. | Geron Corp. COM | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 11.930 $ | 0,53 | 8.007 | |
| Ultragenyx Pharmaceuticals Inc | Ultragenyx Pharmaceuticals Inc COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 11.732 $ | 0,52 | 560 | |
| Genus PLC | Genus PLC ORD GBP0.10 | EC | GB0002074580 | Long | Börsenkurs (Stufe 1) | 10.095 $ | 0,45 | 323 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 9.861 $ | 0,44 | 80 | |
| Bio-Techne Corp | Bio-Techne Corp COM | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 9.668 $ | 0,43 | 185 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 9.292 $ | 0,41 | 427 | |
| Schrodinger Inc. | Schrodinger Inc. COM | EC | 80810D103 | Long | Börsenkurs (Stufe 1) | 8.497 $ | 0,38 | 748 | |
| Tyson Foods, Inc. | Tyson Foods, Inc. CL A | EC | 902494103 | Long | Börsenkurs (Stufe 1) | 8.457 $ | 0,37 | 132 | |
| Caribou Biosciences Inc | Caribou Biosciences Inc COM | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 8.385 $ | 0,37 | 4.413 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 8.272 $ | 0,37 | 25 | |
| Oxford Nanopore Technologies Plc | Oxford Nanopore Technologies Plc ORD GBP0.0001 | EC | GB00BP6S8Z30 | Long | Börsenkurs (Stufe 1) | 8.119 $ | 0,36 | 5.557 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc CL A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 7.350 $ | 0,32 | 2.394 | |
| Rocket Pharmaceuticals Inc | Rocket Pharmaceuticals Inc COM | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 7.278 $ | 0,32 | 2.033 | |
| Nufarm Ltd. | Nufarm Ltd. NPV | EC | AU000000NUF3 | Long | Börsenkurs (Stufe 1) | 6.328 $ | 0,28 | 4.529 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc COM | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 5.898 $ | 0,26 | 12 | |
| Pacific Biosciences Of California Inc. | Pacific Biosciences Of California Inc. COM | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 5.770 $ | 0,25 | 4.371 | |
| QIAGEN NV | QIAGEN NV ORD SHARES | EC | NL0015002SN0 | Long | Börsenkurs (Stufe 1) | 5.405 $ | 0,24 | 135 | |
| Fate Therapeutics Inc. | Fate Therapeutics Inc. COM | EC | 31189P102 | Long | Börsenkurs (Stufe 1) | 5.030 $ | 0,22 | 4.192 | |
| FMC Corp. | FMC Corp. COM NEW | EC | 302491303 | Long | Börsenkurs (Stufe 1) | 4.598 $ | 0,20 | 267 | |
| Biohaven Ltd | Biohaven Ltd COM | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 3.291 $ | 0,15 | 389 | |
| 2.260.539 $ | 99,85 | 122.325 |